These actions, along with the decreased insulin requirements, can subsequently lead to weight loss and further enhancement in peripheral insulin sensitivity, an effect which is becoming increasingly important in light of the ever-growing prevalence of obesity among patients with T1DM [35]. The gene discussed is INS; the disease is Obesity.